Regan MM - Search Results

1

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials.

Kwak L, Ravi P, Armstrong JG, Beckendorf V, Chin JL, D'Amico AV, Dearnaley DP, Di Stasi SM, Gillessen S, Lukka H, Mottet N, Pommier P, Seiferheld W, Sydes MR, Tombal B, Zapatero A, Regan MM, Xie W, Sweeney CJ. Kwak L, et al. Among authors: regan mm. J Clin Oncol. 2024 Jun 20;42(18):2132-2138. doi: 10.1200/JCO.23.00762. Epub 2024 Mar 12. J Clin Oncol. 2024. PMID: 38471051

2

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.

Nakabayashi M, Xie W, Regan MM, Jackman DM, Kantoff PW, Oh WK. Nakabayashi M, et al. Among authors: regan mm. Cancer. 2006 Sep 1;107(5):975-81. doi: 10.1002/cncr.22085. Cancer. 2006. PMID: 16862573 Free article.

3

Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer.

Taplin ME, Xie W, Bubley GJ, Ernstoff MS, Walsh W, Morganstern DE, Regan MM. Taplin ME, et al. Among authors: regan mm. J Clin Oncol. 2006 Dec 1;24(34):5408-13. doi: 10.1200/JCO.2006.06.6589. J Clin Oncol. 2006. PMID: 17135641 Clinical Trial.

4

Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer.

Nakabayashi M, Ling J, Xie W, Regan MM, Oh WK. Nakabayashi M, et al. Among authors: regan mm. Cancer J. 2007 Mar-Apr;13(2):125-9. doi: 10.1097/PPO.0b013e3180465940. Cancer J. 2007. PMID: 17476141

5

Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.

Xie W, Nakabayashi M, Regan MM, Oh WK. Xie W, et al. Among authors: regan mm. Cancer. 2007 Dec 15;110(12):2709-15. doi: 10.1002/cncr.23111. Cancer. 2007. PMID: 17960608 Free article.

6

Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer.

Ross RW, Oh WK, Xie W, Pomerantz M, Nakabayashi M, Sartor O, Taplin ME, Regan MM, Kantoff PW, Freedman M. Ross RW, et al. Among authors: regan mm. J Clin Oncol. 2008 Feb 20;26(6):842-7. doi: 10.1200/JCO.2007.13.6804. J Clin Oncol. 2008. PMID: 18281655

7

Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.

Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O; Prostate Specific Antigen Working Group. Arlen PM, et al. Among authors: regan mm. J Urol. 2008 Jun;179(6):2181-5; discussion 2185-6. doi: 10.1016/j.juro.2008.01.099. Epub 2008 Apr 18. J Urol. 2008. PMID: 18423743 Free PMC article.

8

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK. Choueiri TK, et al. Among authors: regan mm. Cancer. 2009 Mar 1;115(5):981-7. doi: 10.1002/cncr.24064. Cancer. 2009. PMID: 19152438 Free PMC article.

9

Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.

Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW. Chan JM, et al. Among authors: regan mm. J Clin Oncol. 2009 Aug 1;27(22):3577-83. doi: 10.1200/JCO.2008.18.8938. Epub 2009 Jun 15. J Clin Oncol. 2009. PMID: 19528373 Free PMC article.

10

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK. Heng DY, et al. Among authors: regan mm. J Clin Oncol. 2009 Dec 1;27(34):5794-9. doi: 10.1200/JCO.2008.21.4809. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters